Friday, July 10, 2026

pharma · Retinitis Pigmentosa · Dyslipidaemia

HRA Pharma

HRA Pharma clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CHATILLON, USA HQ
121 Employees
EMA registrant Type
Company details
Status
Public
HQ
CHATILLON, USA
Employees
121
Programs
11
Drugs
17
Patents
0
Intelligence · Clinical Programs

HRA Pharma projects

2 ClinicalTrials.gov programs sponsored by HRA Pharma.

HRA Pharma has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. D-CURE 25000 UI gélules., Placebo of vitamin D

    Laboratoire HRA Pharma

    Periodontitis

    approved small molecule active

    1 trial
  2. NAABAK eyedrops

    Laboratoire HRA Pharma

    Allergic Conjunctivitis

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does HRA Pharma have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.